about
Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage responseNBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint controlCCDC98 targets BRCA1 to DNA damage sitesRegulation of BRCA2 gene expression by the SLUG repressor protein in human breast cellsDown-regulation of UCRP and UBE2L6 in BRCA2 knocked-down human breast cellsUnderstanding the development of human bladder cancer by using a whole-organ genomic mapping strategySkp2: a novel potential therapeutic target for prostate cancerNegative Regulation of AKT Activation by BRCA1High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugsTrypanosoma brucei BRCA2 acts in antigenic variation and has undergone a recent expansion in BRC repeat number that is important during homologous recombinationGlobal approaches to understanding ubiquitination.A common missense variant in BRCA2 predisposes to early onset breast cancer.Pancreatic Cancer GeneticsTumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapyExploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsA guide for functional analysis of BRCA1 variants of uncertain significanceSystems biology of cisplatin resistance: past, present and futureBARD1 may be renamed ROW1 because it functions mainly as a REPRESSOR OF WUSCHEL1Fine tuning chemotherapy to match BRCA1 statusA novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report.Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysisSurface plasmon resonance: a versatile technique for biosensor applicationsBRCA2 acts as a RAD51 loader to facilitate telomere replication and cappingGenetic testing for RAD51C mutations: in the clinic and communityBRCA1 and Oxidative StressHistone ubiquitination associates with BRCA1-dependent DNA damage responsePrepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary glandEvolutionary genomics of human intellectual disability'Omic approaches to preventing or managing metastatic breast cancerClassifying Variants of Undetermined Significance in BRCA2 with protein likelihood ratios.Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopySmall interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions.A role for MRE11, NBS1, and recombination junctions in replication and stable maintenance of EBV episomes.Cell-to-cell stochastic variation in gene expression is a complex genetic trait.Mutation of Arabidopsis BARD1 causes meristem defects by failing to confine WUSCHEL expression to the organizing center.Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals.Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancersThe prevalence of BRCA1 mutations among young women with triple-negative breast cancer.
P2860
Q24306765-0D8E5892-1012-4253-815D-CC509B0267EBQ24317325-93E6B30F-3AC9-4DAF-A8A9-82DDA179EBD1Q24321418-52713C83-F0FB-4B18-9088-A54101AFBE35Q24595138-DCF9FE51-83B7-46DD-99D6-9FB2D961D01FQ24603819-899BEE37-9631-4DFD-8992-A4646339DF6EQ24604540-58FC58FB-BC72-4D23-9103-9E70CA788C3FQ24625558-5D18C1FB-3913-4626-9591-FA8775877952Q24644153-67924A64-B994-4F24-AA2B-746183143635Q24644255-CF2C48F6-3663-48CF-9645-2F0A7192BB46Q24646998-8BD946D5-359F-40E1-A631-7738B4DAF23DQ24812618-D596EB3D-1470-4A6D-9E9C-462E17F6C205Q25257499-F89A8D73-A326-4FCC-A51A-E4A95DD583FCQ26765235-53CEB8D3-C56D-4194-93F6-B694D2E2A912Q26768521-A4C37B92-95CA-446E-83CE-E834A2FB5038Q26796590-BA5C4EB0-2662-411E-AAEE-2B241731173DQ26829268-945D346A-8972-4C25-99FC-230AAA62C9A9Q26863585-5B6CC1A8-4375-4C79-9BCD-3DB79B457E26Q27487849-840F531F-00F4-4894-8265-9E79A9DD0662Q27694529-E62C58E7-CB5E-4A44-9B7B-39E3FF2B87A5Q27852587-3B35C47C-FF26-45E1-B596-23AC611B5E72Q28071479-DB4274B2-D270-4018-A053-E9A727DA352BQ28084507-D9E86AAD-55F9-47B5-81DE-3B1A0F5E3B09Q28115349-1760C100-3A5C-4DD9-8076-66830726F012Q28253197-2DFCA65D-68EA-4C02-A15B-4D214114A80BQ28388921-5FCBBFBC-ABDA-4BDF-AA9D-23475B2AC067Q28506770-7C1F788E-6F0F-459A-A632-A68C6DF07B17Q28573752-D32084F9-4374-48F4-B50E-3DB6299231E1Q28729961-A42213AD-34EC-4EC1-8B62-04BD7F8ED8CAQ28730572-C92E5F83-B189-45A4-8724-A24478E8763CQ30373569-78CADB0E-10DA-41D4-AF25-EC71745546EEQ30410984-B5174C2C-8FFD-46F9-8CC2-AB6BD5A0CCFAQ30439093-39B16D8E-58E8-44EB-AA53-5FC1AE17551DQ30682911-C3572000-D2EF-41F3-B37F-DC94AC9BEC33Q33258367-38D5C11E-A065-4BF6-9554-AA9AE9FE19CEQ33307378-B6428277-73C9-4C89-B058-AA7AA0DCE496Q33327696-FC093188-7F3C-4359-93F1-4F5F759E6378Q33345727-E5057151-DBB4-480F-A31C-D95D1F968E18Q33355677-DFEEDD4F-82EA-41D4-B457-9BCE48CA3FBCQ33379276-4B70B414-5703-4261-8D7D-FBF7BCFB5E98Q33419708-9F976075-DD5A-4D8D-B247-23785D2AFE22
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
BRCA1 and BRCA2: 1994 and beyond.
@ast
BRCA1 and BRCA2: 1994 and beyond.
@en
BRCA1 and BRCA2: 1994 and beyond.
@nl
type
label
BRCA1 and BRCA2: 1994 and beyond.
@ast
BRCA1 and BRCA2: 1994 and beyond.
@en
BRCA1 and BRCA2: 1994 and beyond.
@nl
prefLabel
BRCA1 and BRCA2: 1994 and beyond.
@ast
BRCA1 and BRCA2: 1994 and beyond.
@en
BRCA1 and BRCA2: 1994 and beyond.
@nl
P356
P1476
BRCA1 and BRCA2: 1994 and beyond.
@en
P2888
P304
P356
10.1038/NRC1431
P407
P577
2004-09-01T00:00:00Z
P5875
P6179
1016211736